Pressure BioSciences, Inc. PBIO today announced continued strong financial performance for the three and nine month periods ended September 30, 2010, compared to the same periods in 2009.
Total revenue for the third quarter of 2010 was $372,103 compared to $317,427 for the comparable period in 2009, a 17% increase.
Loss per common share – basic and diluted – was $0.26 for the third quarter of 2010 compared to $0.35 for the third quarter of 2009. Loss per common share – basic and diluted – was $1.01 for the nine months ended September 30, 2010 compared to $1.07 for the same nine-month period of 2009.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in